CLINICAL_TRIALS
trial_result
· 2017-03-29
Clinical Trial Update: Medication Development in Alcoholism: Acamprosate Versus Naltrexone [Phase 2]
Summary
A Phase 2 randomized trial comparing acamprosate and naltrexone for alcoholism has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Scripps Research Institute | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2017-03-29